scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00418-011-0802-6 |
P698 | PubMed publication ID | 21431875 |
P50 | author | Uta Dahmen | Q61159946 |
Haoshu Fang | Q82784124 | ||
P2093 | author name string | Wei Dong | |
Jian Sun | |||
Hao Jin | |||
Anding Liu | |||
Olaf Dirsch | |||
P2860 | cites work | Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain | Q42521053 |
Protective effects of early CD4(+) T cell reduction in hepatic ischemia/reperfusion injury | Q43235979 | ||
The Microcirculatory Acinar Concept of Normal and Pathological Hepatic Structure | Q43625947 | ||
Remote renal injury following partial hepatic ischemia/reperfusion injury in rats | Q44697977 | ||
High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation | Q46339712 | ||
Antioxidant defense in hepatic ischemia-reperfusion injury is regulated by damage-associated molecular pattern signal molecules | Q46448854 | ||
Recovery of liver perfusion after focal outflow obstruction and liver resection | Q46704674 | ||
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice | Q47214457 | ||
Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. | Q51756458 | ||
Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. | Q54189585 | ||
Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High-Mobility Group Box Chromosomal Protein 1 | Q60692900 | ||
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart | Q63384080 | ||
The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat | Q71048207 | ||
Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation | Q71567219 | ||
Activation of gene expression in human neutrophils by high mobility group box 1 protein | Q73087842 | ||
Direct induction of acute lung and myocardial dysfunction by liver ischemia and reperfusion | Q73842241 | ||
Mechanism of hepatocyte death after ischemia: apoptosis versus necrosis | Q73969330 | ||
HMGB1: endogenous danger signaling | Q24645232 | ||
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 | ||
High mobility group box 1 protein interacts with multiple Toll-like receptors | Q28280114 | ||
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system | Q28567291 | ||
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes | Q28574795 | ||
DAMPs, PAMPs and alarmins: all we need to know about danger | Q29547535 | ||
How dying cells alert the immune system to danger | Q29615501 | ||
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion | Q33193752 | ||
Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. | Q34253619 | ||
New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal | Q34334123 | ||
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning | Q35028609 | ||
Hepatic ischemia/reperfusion injury--a fresh look | Q35113326 | ||
Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection | Q35177479 | ||
Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury | Q35546843 | ||
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function | Q35661137 | ||
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response | Q35920321 | ||
TLR4 activation mediates kidney ischemia/reperfusion injury | Q35987574 | ||
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. | Q35990737 | ||
HMGB1: guiding immunity from within | Q36174866 | ||
HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling | Q36229208 | ||
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion | Q36403403 | ||
Factors in the pathophysiology of the liver ischemia-reperfusion injury | Q36743874 | ||
High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity | Q36990574 | ||
Molecular mediators of liver ischemia and reperfusion injury: a brief review | Q37091752 | ||
HMGB1 is an endogenous immune adjuvant released by necrotic cells | Q40104101 | ||
Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion | Q40206560 | ||
Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. | Q40234022 | ||
The extracellular release of HMGB1 during apoptotic cell death | Q40253423 | ||
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein | Q40609759 | ||
Release of danger signals during ischemic storage of the liver: a potential marker of organ damage? | Q41488547 | ||
Quantitative evaluation and selection of reference genes in a rat model of extended liver resection | Q42223108 | ||
P433 | issue | 5 | |
P304 | page(s) | 443-452 | |
P577 | publication date | 2011-03-24 | |
P1433 | published in | Histochemistry and Cell Biology | Q1524012 |
P1476 | title | HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat | |
P478 | volume | 135 |
Q41824288 | 7,8-dihydroxycoumarin has a dual mechanism of action in hepatic ischemia reperfusion injury |
Q42094967 | Autophagy and liver ischemia-reperfusion injury. |
Q36875109 | Baicalein pretreatment reduces liver ischemia/reperfusion injury via induction of autophagy in rats |
Q37433294 | Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β. |
Q46980971 | Cross-Talk Between Sirtuin 1 and High-Mobility Box 1 in Steatotic Liver Graft Preservation |
Q41764934 | Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase. |
Q51066423 | G-CSF pretreatment aggravates LPS-associated microcirculatory dysfunction and acute liver injury after partial hepatectomy in rats. |
Q34622835 | HMGB1 in health and disease |
Q84272970 | HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats |
Q40302106 | Identification of Proteins Interacting with Cytoplasmic High-Mobility Group Box 1 during the Hepatocellular Response to Ischemia Reperfusion Injury |
Q36529189 | Impact of intestinal ischemia/reperfusion and lymph drainage on distant organs in rats |
Q41050095 | Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model |
Q37694640 | Ischemic preconditioning attenuates ischemia/reperfusion injury in rat steatotic liver: role of heme oxygenase-1-mediated autophagy |
Q38725134 | Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses |
Q28579337 | Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion |
Q41330901 | Pretreatment of cisplatin in recipients attenuates post-transplantation pancreatitis in murine model |
Q34172616 | Recent progress in histochemistry and cell biology |
Q41050078 | Relevance of proteolysis and proteasome activation in fatty liver graft preservation: An Institut Georges Lopez-1 vs University of Wisconsin appraisal |